BioNTech's reported earnings miss and the issuance of weaker guidance for the next fiscal year directly impact investor sentiment and the stock's short-term performance. Given the direct correlation between earnings reports, guidance, and stock price movements, it's likely that BNTX will experience downward pressure in the short term.